S-EQUOL PLUS Laboratory Results — Lot 260427
Quality / Public Verification View
Independent laboratory results for S-EQUOL PLUS.
- Laboratory
- Bis Laboratories
- Report number
- 2605014-1
- Report date
- May 15, 2026
- Product
- S-EQUOL PLUS
- NPN recorded on report
- 80143622
- Lot
- 260427
Download laboratory results (PDF summary) ↗
The downloadable public summary is prepared by DR.MORGAN from the named independent laboratory report. It is not the original laboratory-issued certificate.
Results and report limits
Each result below is transcribed from the identified report. “<” means the reported result is below the stated reporting threshold. Heavy-metal results are expressed in micrograms per kilogram body weight per day (µg/kg b.w./day), using the report’s 70 kg adult body-weight assumption and one-capsule-per-day calculation. This calculation is a laboratory exposure basis, not an instruction for use.
- Arsenic
- Result: < 0.00053 µg/kg b.w./day. Report limit: < 0.14 µg/kg b.w./day. Method: USP <233>.
- Cadmium
- Result: < 0.00007 µg/kg b.w./day. Report limit: < 0.09 µg/kg b.w./day. Method: USP <233>.
- Lead
- Result: < 0.00028 µg/kg b.w./day. Report limit: < 0.14 µg/kg b.w./day. Method: USP <233>.
- Mercury
- Result: < 0.00024 µg/kg b.w./day. Report limit: < 0.29 µg/kg b.w./day. Method: USP <233>.
- Total aerobic microbial count (TAMC)
- Result: < 10 CFU/g. Report limit: < 10000 CFU/g. Method: USP <2021>.
- Total yeast and mould count (TYMC)
- Result: < 10 CFU/g. Report limit: < 1000 CFU/g. Method: USP <2021>.
- Salmonella spp.
- Result: Absent. Report limit: Absent in 10 g. Method: USP <2022>.
- Escherichia coli
- Result: Absent. Report limit: Absent in 10 g. Method: USP <2022>.
- Staphylococcus aureus
- Result: Absent. Report limit: Absent in 10 g. Method: USP <2022>.
- Disintegration
- Result: 11 min 30 sec. Report limit: ≤ 30 min. Method: USP <2040>.
Heavy-metal limits are identified in the report as based on Health Canada’s Quality of Natural Health Products Guide. Microbiological limits are identified as based on USP <2023>.
The disintegration limit is identified as based on USP <2040>.
Scope and limitations
These results apply only to the sample and lot identified in this report. They do not establish clinical efficacy, confirm every ingredient amount, or demonstrate results for every production batch. This page does not identify the lot currently being shipped. Follow the current product label and licensed information for use.
This public verification view presents relevant testing information without distributing the original report. Recipient details, private contact information and approval signatures are omitted.
Batch-specific manufacturing and quality documentation is available upon request and is reviewed manually by DR.MORGAN.
